Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis.
Apolipoproteins
Potential communicators of lipoproteins
The pathogenesis of early atherosclerosis
Treatment of early atherosclerosis
Journal
International journal of biological sciences
ISSN: 1449-2288
Titre abrégé: Int J Biol Sci
Pays: Australia
ID NLM: 101235568
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
05
2023
accepted:
15
08
2023
medline:
3
10
2023
pubmed:
2
10
2023
entrez:
2
10
2023
Statut:
epublish
Résumé
Atherosclerosis as the leading cause of the cardiovascular disease is closely related to cholesterol deposition within subendothelial areas of the arteries. Significantly, early atherosclerosis intervention is the critical phase for its reversal. As atherosclerosis progresses, early foam cells formation may evolve into fibrous plaques and atheromatous plaque, ulteriorly rupture of atheromatous plaque increases risks of myocardial infarction and ischemic stroke, resulting in high morbidity and mortality worldwide. Notably, amphiphilic apolipoproteins (Apos) can concomitantly combine with lipids to form soluble lipoproteins that have been demonstrated to associate with atherosclerosis. Apos act as crucial communicators of lipoproteins, which not only can mediate lipids metabolism, but also can involve in pro-atherogenic and anti-atherogenic processes of atherosclerosis via affecting subendothelial retention and aggregation of low-density lipoprotein (LDL), oxidative modification of LDL, foam cells formation and reverse cholesterol transport (RCT) in macrophage cells. Correspondingly, Apos can be used as endogenous and/or exogenous targeting agents to effectively attenuate the development of atherosclerosis. The article reviews the classification, structure, and relationship between Apos and lipids, how Apos serve as communicators of lipoproteins to participate in the pathogenesis progression of early atherosclerosis, as well as how Apos as the meaningful targeting mass is used in early atherosclerosis treatment.
Identifiants
pubmed: 37781031
doi: 10.7150/ijbs.86475
pii: ijbsv19p4493
pmc: PMC10535700
doi:
Substances chimiques
Apolipoproteins
0
Cholesterol
97C5T2UQ7J
Lipoproteins
0
Lipoproteins, LDL
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
4493-4510Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
J Clin Lipidol. 2014 Jan-Feb;8(1):86-93
pubmed: 24528689
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45
pubmed: 21487090
Atherosclerosis. 2012 Nov;225(1):39-40
pubmed: 23040866
J Am Heart Assoc. 2021 Jul 20;10(14):e021261
pubmed: 34240614
Curr Opin Lipidol. 2004 Oct;15(5):505-14
pubmed: 15361785
FASEB J. 2015 May;29(5):1688-700
pubmed: 25550461
Anatol J Cardiol. 2017 Aug;18(2):149-154
pubmed: 28766509
Biomolecules. 2020 May 29;10(6):
pubmed: 32485898
Proteomics. 2009 Mar;9(5):1344-52
pubmed: 19253276
PLoS One. 2013 Jul 09;8(7):e68802
pubmed: 23874769
Circulation. 2006 Feb 7;113(5):691-700
pubmed: 16461842
Curr Opin Lipidol. 2005 Jun;16(3):287-94
pubmed: 15891389
J Lipid Res. 2010 Aug;51(8):2191-201
pubmed: 20332422
Lipids Health Dis. 2018 Sep 17;17(1):220
pubmed: 30223835
J Intern Med. 2004 Feb;255(2):188-205
pubmed: 14746556
Front Neurosci. 2019 Feb 28;13:164
pubmed: 30872998
Exp Mol Med. 2011 Jan 31;43(1):53-61
pubmed: 21270507
Biomater Sci. 2020 Jul 21;8(14):3784-3799
pubmed: 32469010
J Lipid Res. 2001 Sep;42(9):1346-67
pubmed: 11518754
Biochem J. 2007 Apr 15;403(2):359-67
pubmed: 17206937
Acta Pharmacol Sin. 2013 Jun;34(6):837-46
pubmed: 23564081
J Mol Med (Berl). 2005 May;83(5):329-42
pubmed: 15827760
Biochem Biophys Res Commun. 2001 Jan 26;280(3):818-23
pubmed: 11162594
Biochemistry (Mosc). 2016 Nov;81(11):1358-1370
pubmed: 27914461
Int J Mol Sci. 2013 Feb 25;14(3):4419-31
pubmed: 23439550
J Biol Chem. 2002 Jul 19;277(29):26565-72
pubmed: 12000760
Curr Atheroscler Rep. 2006 Nov;8(6):501-9
pubmed: 17045077
Curr Opin Lipidol. 2013 Aug;24(4):295-300
pubmed: 23652568
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):219-25
pubmed: 17038637
Eur Heart J. 2018 Jul 14;39(27):2562-2573
pubmed: 29982602
Free Radic Res. 2017 Apr;51(4):439-447
pubmed: 28412863
Fish Shellfish Immunol. 2019 Sep;92:111-118
pubmed: 31176005
Trends Cardiovasc Med. 2003 Aug;13(6):226-31
pubmed: 12922018
Brain Behav. 2021 Sep;11(9):e2328
pubmed: 34423582
J Biol Chem. 2006 Jul 14;281(28):19732-9
pubmed: 16704977
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):224-31
pubmed: 23241412
Atherosclerosis. 2012 Mar;221(1):91-7
pubmed: 22204862
Cancer Med. 2019 Nov;8(16):7032-7043
pubmed: 31573738
J Pediatr. 2020 Dec;227:199-203.e1
pubmed: 32795477
Front Pharmacol. 2021 Feb 15;11:556074
pubmed: 33658920
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):564-70
pubmed: 14726411
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):246-52
pubmed: 19965776
J Lipid Res. 2014 Feb;55(2):168-79
pubmed: 23812558
Sci Signal. 2015 Aug 11;8(389):ra79
pubmed: 26268607
Metabolism. 2018 Jan;78:155-166
pubmed: 28986164
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):156-63
pubmed: 19778948
J Lipid Res. 2008 Feb;49(2):324-31
pubmed: 17978313
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1325-31
pubmed: 15831812
Atherosclerosis. 2021 Oct;334:76-84
pubmed: 34482091
J Intern Med. 2006 May;259(5):493-519
pubmed: 16629855
Clin Sci (Lond). 2010 Mar 30;118(12):727-36
pubmed: 20102334
Cell Mol Life Sci. 2004 Jan;61(1):4-9
pubmed: 14704849
Circulation. 2006 Aug 15;114(7):681-7
pubmed: 16894036
Mol Med Rep. 2019 Oct;20(4):3285-3291
pubmed: 31432166
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9613-8
pubmed: 21606363
J Am Coll Cardiol. 2010 Jun 8;55(23):2580-9
pubmed: 20513599
J Am Heart Assoc. 2013 May 24;2(3):e000048
pubmed: 23709562
Metabolism. 2020 Dec;113:154395
pubmed: 33058850
J Lipid Res. 2003 Jan;44(1):22-32
pubmed: 12518019
Biochem Biophys Res Commun. 2011 Nov 25;415(3):497-502
pubmed: 22056562
Lipids Health Dis. 2016 Oct 22;15(1):184
pubmed: 27770802
J Biol Chem. 2001 Dec 7;276(49):46011-6
pubmed: 11590165
Circulation. 2011 Nov 29;124(22):2433-43, 1-7
pubmed: 22064596
J Pharmacol Exp Ther. 2010 Aug;334(2):634-41
pubmed: 20484557
Cardiovasc Ther. 2022 Jan 10;2022:4610834
pubmed: 35087605
Am J Pathol. 2000 Dec;157(6):1839-48
pubmed: 11106557
J Lipid Res. 2003 Apr;44(4):828-36
pubmed: 12562845
Atherosclerosis. 2007 Nov;195(1):e9-16
pubmed: 17320883
Coron Artery Dis. 2016 Nov;27(7):592-603
pubmed: 27414247
Can J Cardiol. 2017 Mar;33(3):325-333
pubmed: 28063740
Atherosclerosis. 2019 Feb;281:17-24
pubmed: 30594773
Circulation. 2000 Feb 1;101(4):352-5
pubmed: 10653823
Nature. 2002 Jun 13;417(6890):750-4
pubmed: 12066187
Cardiovasc Res. 2015 Sep 1;107(4):579-89
pubmed: 26160324
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158541
pubmed: 31672573
J Cell Mol Med. 2017 Dec;21(12):3810-3820
pubmed: 28767201
Eur Heart J. 2013 Feb;34(8):615-24
pubmed: 22927557
Biochem Biophys Res Commun. 2012 Apr 20;420(4):851-6
pubmed: 22465014
J Lipid Res. 2008 Jan;49(1):115-26
pubmed: 17921435
Expert Opin Investig Drugs. 2015;24(10):1389-98
pubmed: 26364508
J Biol Chem. 2003 Sep 19;278(38):36257-63
pubmed: 12857755
Biomolecules. 2021 Apr 23;11(5):
pubmed: 33922449
Atherosclerosis. 2010 Jan;208(1):134-41
pubmed: 19656510
Atherosclerosis. 2021 Jan;316:32-40
pubmed: 33296791
Can J Cardiol. 2017 Jul;33(7):872-882
pubmed: 28365054
Int J Mol Med. 2012 Mar;29(3):510-4
pubmed: 22160096
JCI Insight. 2018 Feb 22;3(4):
pubmed: 29467335
Ann Clin Biochem. 2011 Nov;48(Pt 6):498-515
pubmed: 22028427
J Mol Cell Cardiol. 2017 Apr;105:77-88
pubmed: 28274624
Arch Biochem Biophys. 2008 Nov 1;479(1):1-14
pubmed: 18713619
J Biol Chem. 2004 Jul 9;279(28):29195-201
pubmed: 15131109
Cells. 2019 Apr 05;8(4):
pubmed: 30959835
Mol Biol Rep. 2013 Sep;40(9):5429-38
pubmed: 23681550
Front Pharmacol. 2017 Jan 06;7:526
pubmed: 28111551
Nat Med. 2019 Mar;25(3):496-506
pubmed: 30692699
Circ Res. 2016 Feb 19;118(4):668-78
pubmed: 26892965
Clin Chim Acta. 2016 Sep 1;460:50-4
pubmed: 27318213
Atherosclerosis. 2017 Dec;267:49-60
pubmed: 29100061
J Cardiovasc Pharmacol. 2018 Jul;72(1):60-67
pubmed: 29738371
FASEB J. 2007 Aug;21(10):2312-22
pubmed: 17412999
J Clin Invest. 2004 Feb;113(4):569-81
pubmed: 14966566
J Lipid Res. 2018 Jul;59(7):1244-1255
pubmed: 29773713
Circ Res. 2013 May 24;112(11):1479-90
pubmed: 23542898
Antioxid Redox Signal. 2007 Mar;9(3):301-7
pubmed: 17184171
J Lipid Res. 2013 Jun;54(6):1578-1588
pubmed: 23528259
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
Mol Biol Rep. 2021 Jan;48(1):875-886
pubmed: 33389539
Lipids Health Dis. 2019 May 22;18(1):117
pubmed: 31113434
Prog Lipid Res. 2004 Jul;43(4):350-80
pubmed: 15234552
Circ Res. 2016 Feb 19;118(4):535-46
pubmed: 26892956
Curr Opin Lipidol. 2016 Oct;27(5):473-83
pubmed: 27472409
J Cell Mol Med. 2019 Jun;23(6):4063-4075
pubmed: 30950217
Circulation. 2005 Nov 29;112(22):3375-83
pubmed: 16316964
Endocr Rev. 2019 Apr 1;40(2):537-557
pubmed: 30312399
Biomolecules. 2019 Jul 25;9(8):
pubmed: 31349600
Thromb Haemost. 2008 Jul;100(1):110-8
pubmed: 18612545
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):99-105
pubmed: 16269668
Circ Res. 2015 Nov 6;117(11):933-42
pubmed: 26358193
Atherosclerosis. 2021 Mar;320:10-18
pubmed: 33497863
Biol Rev Camb Philos Soc. 2015 May;90(2):367-76
pubmed: 24834836
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1558-64
pubmed: 19696405
Physiol Rev. 2003 Oct;83(4):1069-112
pubmed: 14506301
FEBS Lett. 2003 Apr 10;540(1-3):181-7
pubmed: 12681505
Front Endocrinol (Lausanne). 2020 Jul 28;11:474
pubmed: 32849270
Curr Opin Lipidol. 2019 Aug;30(4):326-341
pubmed: 31157629
Inflammation. 2019 Apr;42(2):606-617
pubmed: 30377890
J Lipid Res. 2012 Sep;53(9):1832-9
pubmed: 22717515
Ageing Res Rev. 2017 Aug;37:146-161
pubmed: 28647612
Metabolism. 2020 Aug;109:154296
pubmed: 32562799
Am J Med Sci. 2016 Oct;352(4):408-415
pubmed: 27776723
Atherosclerosis. 2015 Apr;239(2):589-98
pubmed: 25734982
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11779-84
pubmed: 15280540
Ann Glob Health. 2014 Jan-Feb;80(1):13-23
pubmed: 24751561
J Biol Chem. 2008 Jan 25;283(4):1839-47
pubmed: 18006500
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
Curr Opin Lipidol. 2019 Dec;30(6):477-484
pubmed: 31592794
J Physiol Biochem. 2017 May;73(2):287-296
pubmed: 28181168
Int J Mol Sci. 2018 Nov 06;19(11):
pubmed: 30404132
J Lipid Res. 2015 Jun;56(6):1206-21
pubmed: 25861792
Mass Spectrom Rev. 2023 Jul-Aug;42(4):1397-1423
pubmed: 34747518
Diabetes. 2009 Sep;58(9):2018-26
pubmed: 19502413
Metabolites. 2021 Oct 08;11(10):
pubmed: 34677405
Circulation. 2011 Nov 8;124(19):2065-72
pubmed: 21986282
Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2813-20
pubmed: 23152494
Trends Cardiovasc Med. 2019 Jan;29(1):22-26
pubmed: 29934015
Curr Opin Lipidol. 2015 Feb;26(1):48-55
pubmed: 25551802
PLoS One. 2013;8(1):e54628
pubmed: 23359805
J Biol Chem. 2001 Jul 6;276(27):25043-8
pubmed: 11350966
Pharmacol Rev. 2019 Oct;71(4):596-670
pubmed: 31554644
Tohoku J Exp Med. 2010 Mar;220(3):223-8
pubmed: 20208418
Circ Res. 2019 May 10;124(10):1505-1518
pubmed: 31071007
Trends Pharmacol Sci. 2015 Oct;36(10):675-687
pubmed: 26435212
Circ Res. 2013 Jan 18;112(2):278-88
pubmed: 23123430
Chin Med J (Engl). 2015 Sep 20;128(18):2530-4
pubmed: 26365974
Curr Drug Targets. 2008 Mar;9(3):196-203
pubmed: 18336237
Atherosclerosis. 2007 Sep;194(1):116-24
pubmed: 17126342
Biochemistry. 2006 Oct 3;45(39):11799-808
pubmed: 17002280
Thromb Haemost. 2014 Aug;112(2):332-41
pubmed: 24816772
J Clin Invest. 2004 Feb;113(4):609-18
pubmed: 14966570